固相萃取-气相色谱法同时检测水产品中的氯霉素、甲砜霉素、氟苯尼考和氟苯尼考胺

建立了同时测定水产品中氯霉素、甲砜霉素、氟苯尼考和氟苯尼考胺的固相萃取-气相色谱方法。用98:2(V/V)的乙酸乙酯和氨水提取鱼体中的氯霉素、甲砜霉素、氟苯尼考和氟苯尼考胺,用MCX固相萃取小柱对提取物进行净化和富集,经98:2(V/V)的甲醇和氨水混合溶液洗脱后氮吹浓缩,并用乙腈复溶,再用BSTFA衍生化和气相色谱仪检测。实验条件下,氯霉素浓度在5~50μg/L范围,甲砜霉素、氟苯尼考和氟苯尼考胺浓度在15~100μg/L范围内线性良好,相关系数分别为0.9909,0.9937,0.9948和0.9916,检出限分别为0.3,1.0,1.0和1.0μg/kg,7次加标回收率为71.8%~105%,相对标准偏差在8.1%~15%之间。     

高效液相色谱-电喷雾电离三级四极杆质谱检测动物源食品中氯霉素、甲砜霉素、氟苯尼考残留量

建立了动物源产品中氯霉素、甲砜霉素、氟苯尼考残留量的高效液相色谱-电喷雾电离三级四极杆质谱(LC-ESI-MS/MS)的方法。前处理方法包括添加同位素内标氯霉素-d5,碱化乙酸乙酯提取,C18小柱净化。该方法采用负离子,多反应监测氯霉素四对离子(321.0/151.9,321.0/256.6,321.0/194.2,321.0/175.4),甲砜霉素两对离子(354.1/185.0,354.1/290.0),氟苯尼考两对离子(356.0/335.9,356.0/185.1)和同位素内标氯霉素-d5(326.0/157.1)。该方法线性范围为0.1~1.6μg/kg;对不同基质样品的加标回收率为80%~112.5%;相对标准偏差小于11%;方法的测定低限为0.1μg/kg。     

改良的QuEChERS与HPLC-HESI/MS/MS同时测定中华鳖组织中氯硝柳胺和酰胺醇类药物及其代谢物的残留量

建立了中华鳖(Trionyx sinensis)组织(血浆、肌肉、裙边、肝脏和肾脏)中氯硝柳胺、氯霉素、甲砜霉素、氟苯尼考和氟苯尼考胺同时测定的高效液相色谱-加热电喷雾电离源串联质谱法(HPLC-HESI/MS/MS)。样品经改进的QuEChERS方法提取净化,以氨化乙腈为提取剂,十八烷基硅烷键合硅胶(C18)粉为净化剂,甲醇-水为流动相,流速为0.3 mL/min,以Waters Symmetry~ C_(18)(2.1 mm×100 mm,3.5μm)为色谱分离柱,采用正负离子分段扫描和多反应监测模式(MRM)检测。氯霉素、甲砜霉素、氟苯尼考和氟苯尼考胺采用内标标准曲线法定量,氯硝柳胺采用基质匹配标准曲线外标法定量。结果表明,在0.3~100μg/L范围内,5种待测物均呈良好的线性关系,相关系数(r2)均不小于0.998 7。在1~20μg/kg加标水平下,中华鳖空白血浆、肌肉、裙边、肝脏和肾脏的加标回收率为77.9%~105.3%(n=6),相对标准偏差为2.7%~10.5%(n=6),方法的检出限分别为0.5、0.1、0.5、0.5、0.5μg/kg,定量下限分别为1.0、0.3、1.0、1.0、1.0μg/kg。该方法操作简便、准确、灵敏度高,适用于中华鳖组织中氯硝柳胺、氯霉素、甲砜霉素、氟苯尼考和氟苯尼考胺残留量的同时测定。     

高效液相色谱-串联质谱法同时测定水产品中氯霉素、甲砜霉素和氟甲砜霉素的残留量

建立了水产品中氯霉素、甲砜霉素和氟甲砜霉素药物残留量同时测定的高效液相色谱-串联质谱方法。以氘代氯霉素做内标,选择乙酸乙酯提取,HLB固相萃取柱净化,洗脱液氮气吹干,采用LC-MS/MS选择反应监测(SRM)负离子模式进行定性、定量分析。结果表明:氯霉素的检出限(LOD)为0.01μg/kg,甲砜霉素和氟甲砜霉素检出限(LOD)为0.03μg/kg,检测结果的相对标准偏差为3.3%～9.7%(n=6),加标回收率达到78.6%～110.5%。该方法在水产品中氯霉素、甲砜霉素和氟甲砜霉素药物的残留测定中具有很好的应用前景。     

超高效液相色谱-串联质谱法测定畜禽副产品中氯霉素和氟甲砜霉素残留量

建立了超高效液相色谱-串联质谱测定畜禽副产品中氯霉素和氟甲砜霉素残留量的方法。样品经碱性乙酸乙酯提取,正己烷脱脂后,直接采用电喷雾电离(ESI)多反应监测(MRM)负离子模式检测,氯霉素用同位素内标定量,氟甲砜霉素用外标法定量。氯霉素和氟甲砜霉素在0.2～50μg/L范围内线性良好,相关系数达到0.9999;检出限均为0.04μg/kg;氯霉素回收率为89.6%～112.0%,RSD为5.4%～8.1%;氟甲砜霉素回收率为90.3%～110.0%,RSD为5.1%～8.0%。方法可用于畜禽副产品中氯霉素和氟甲砜霉素残留量测定。     

高效液相色谱-串联质谱法同时测定祛痘化妆品中的3种氯霉素类抗生素

建立了祛痘化妆品中氯霉素、甲砜霉素及氟苯尼考等3种氯霉素类抗生素的高效液相色谱-串联质谱检测方法。样品以甲醇为溶剂超声提取,提取液经高速离心及微孔滤膜过滤后,以XBridge Phenyl(2.1 mm×150 mm,3.5μm)色谱柱分离,进行电喷雾负离子多反应监测模式下的定性及定量分析。结果表明,氯霉素、甲砜霉素及氟苯尼考在各自线性范围内线性良好,定量限分别为5,20和10μg/kg。在低、中、高3个添加水平,3种氯霉素类抗生素的回收率为80.6%~117.4%,相对标准偏差(n=6)为4.6%~7.7%。方法能够为祛痘化妆品检验和生产质量控制提供科学依据及技术支持。     

酶联免疫法检测动物组织及尿液中氟苯尼考与甲砜霉素的残留

针对食品中氟苯尼考及甲砜霉素多残留污染问题,基于新设计的半抗原制备了系列人工抗原,通过免疫动物获得了可同时特异性识别氟苯尼考与甲砜霉素的多克隆抗体,并在抗体-包被原组合的筛选及反应条件优化基础上,建立了动物组织及尿液中氟苯尼考和甲砜霉素残留同时检测的酶联免疫分析方法。本方法对于氟苯尼考的半数抑制浓度(IC_(50))为1.32 ng/mL,线性检测范围为0.31~5.61 ng/mL,检出限为0.12 ng/mL;对于甲砜霉素的IC_(50)为2.13 ng/mL,线性检测范围为0.41~11.20 ng/mL,检出限为0.15 ng/mL,与氯霉素等多种类似物均无交叉反应,动物组织及尿样中氟苯尼考和甲砜霉素的添加回收率均在77.2%~116.0%之间,相对标准偏差15%,适用于实际样品中氟苯尼考和甲砜霉素的快速筛查检测。     

超高效液相色谱-串联质谱法测定禽蛋中氯霉素、甲砜霉素和氟甲砜霉素

采用超高效液相色谱-三重四极杆串联质谱,用多反应监测模式定量,建立了禽蛋中氯霉素、甲砜霉素和氟甲砜霉素同时测定的分析方法。添加氯霉素-d5作为内标进行定量,试样经过乙酸乙酯提取,三氯乙酸去蛋白,盐析,分离,再经正己烷去脂肪,省去固相萃取净化步骤,直接上机测定。氯霉素、甲砜霉素和氟甲砜霉素的检出限分别为0.03,0.03和0.015"g/kg,定量限分别为0.10,0.10和0.05"g/kg,3种化合物的加标平均回收率在90.5%~103.5%,相对标准偏差在2.1%~6.0%之间。方法能对禽蛋中的氯霉素类化合物进行检测分析。     

高效液相色谱-串联质谱法同时测定饲料中氯霉素、甲砜霉素与氟甲砜霉素残留量

建立了饲料中氯霉素(CAP)、甲砜霉素(TAP)、氟甲砜霉素(FF)3种抗生素残留量的高效液相色谱-串联质谱(HPLC-MS/MS)测定方法。样品经碱化乙酸乙酯提取,蒸发浓缩,提取物经正己烷脱脂,液-液分配净化后,采用电喷雾电离源(ESI)负离子多反应监测(MRM)模式检测,内标法定量。氯霉素、氟甲砜霉素和甲砜霉素的线性范围分别为0.2～10.0、0.2～10.0、1.0～50.0μg/L,相关系数(r2)不低于0.990 0;其检出限分别为0.1、0.1、0.5μg/kg,定量下限分别为0.3、0.3、1.5μg/kg。3种抗生素药物的平均回收率为77%～108%,相对标准偏差(RSD)不大于10.9%。     

高效液相色谱-电喷雾电离三级四极杆质谱测定鸡肉中氯霉素、甲砜霉素和氟甲砜霉素的残留量

建立了鸡肉中3种氯霉素类抗生素残留的高效液相色谱-电喷雾电离三级四极杆质谱(HPLC-ESI-MS-MS)测定法。该方法采用多反应监测(MRM)负离子模式,可一次对鸡肉中的氯霉素、甲砜霉素和氟甲砜霉素进行定性和定量。该方法仅需1 g样品,并省去固相萃取步骤,具有操作简便、有机试剂消耗量少、测定周期短等优点。方法的检出限为0.010 μg/kg,测定低限为0.100 μg/kg,线性范围为0.050~1.00 μg/L,加标回收率为69.0%~92.8%,相对标准偏差为6.3%~12.9%。     

Simultaneous determination of salidroside and its aglycone metabolite p-tyrosol in rat plasma by liquid chromatography-tandem mass spectrometry

Salidroside and its aglycone p-tyrosol are two major phenols in the genus Rhodiola and have been confirmed to possess various pharmacological properties. In our present study, p-tyrosol was identified as the deglycosylation metabolite of salidroside after intravenous (i.v.) administration to rats at a dose of 50 mg/kg, but was not detectable after intragastric gavage (i.g.) administration through HPLC-photodiode array detection (PDA) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Next, an accurate and precise LC-MS/MS method was developed to quantitatively determine salidroside and p-tyrosol in rat plasma samples. Samples were analyzed by LC-MS/MS on a reverse-phase xTerra MS C18 column which was equilibrated and eluted with an isocratic mixture of acetonitrile-water (1:9, v/v) at a flow rate of 0.3 mL/min. The analytes were monitored by multiple reaction monitoring (MRM) under the negative electrospray ionization mode. The precursor/product transitions (m/z) were 299.0 → 118.8 for salidroside, 137.0 → 118.9 for p-tyrosol and 150.1 → 106.9 for the internal standard (IS), paracetamol, respectively. The calibration curve was linear over the concentration ranges of 50-2,000 ng/mL for salidroside and 20-200 ng/mL for p-tyrosol. The inter- and intra-day accuracy and precision were within ± 15%. The method has been successfully applied to the pharmacokinetic study and the oral bioavailability was calculated.     

Screening flavonoid metabolites of naringin and narirutin in urine after human consumption of grapefruit juice by LC-MS and LC-MS/MS

The main flavonoids in grapefruit juice, naringin and narirutin, were quantified by LC-MS with structural differentiation by LC-MS/MS. After human consumption of grapefruit juice, urine samples were collected for 24 hours and screened for flavonoid metabolites by LC-MS. The metabolite structures (glucuronides, sulfates, and glucuronide sulfates) were then confirmed via their unique fragmentation patterns by LC-MS/MS. To further verify the identity of the common aglycon (naringenin) shared by the metabolites, enzymatic hydrolysis was performed and the resulting products were analyzed. This work demonstrates that LC-MS and LC-MS/MS techniques can be used for fast metabolite screening without extensive sample preparation.     

Simultaneous determination of florfenicol with its metabolite based on modified quick,easy, cheap,effective, rugged,and safe sample pretreatment and evaluation of their degradation behavior in agricultural soils

A simple and simultaneous method for the determination of florfenicol and its metabolite florfenicol amine in agricultural soils using modified quick, easy, cheap, effective, rugged, and safe sample pretreatment and reversed‐phase high‐performance liquid chromatography with tandem mass spectrometry is presented. Florfenicol and its metabolite florfenicol amine residues in agricultural soils were extracted with alkalized acetonitrile and an aliquot was cleaned up with Si(CH₂)₃NH (CH₂)₂NH₂ and C₁₈ sorbent, which were powder materials. High‐performance liquid chromatography with tandem mass spectrometry was applied to simultaneously determine the level of florfenicol and florfenicol amine in agricultural soils. Excellent linearity was achieved for florfenicol and florfenicol amine over a range of concentrations from 0.1–500 μg/L with coefficients more than 0.99. Average recoveries at four different levels (0.005, 0.05, 0.5, and 5.0 mg/kg) for florfenicol and florfenicol amine ranged from 73.6–94.9% with relative standard deviations of 2.9–12.5%. The limits of detection for florfenicol and florfenicol amine in agricultural soils were 2.0 μg/kg, and the limits of quantification were 6.0 μg/kg. Based on this method, the degradation behavior of florfenicol and its metabolite florfenicol amine in three soils (Nanchang, Hangzhou, and Changchun) under sterilized and native conditions was investigated and the transformation rate of florfenicol amine from florfenicol was evaluated.     

液相色谱-串联质谱法测定黄瓜和苹果中氟啶虫酰胺及其代谢产物残留量

建立了黄瓜和苹果中氟啶虫酰胺及其3种代谢产物［N-(4-trifluoromethylnicotinoyl)glycine(TFNG)、4-tri-fluoromethylnicotinic acid(TFNA)和4-trifluoromethylnicotinamide(TFNA-AM)］同时测定的液相色谱-串联质谱分析方法。样品用磷酸盐缓冲液提取两次,调节pH值至1.5～2.0后,再用乙酸乙酯提取,液相色谱-串联质谱分析。采用Acquity BEH C18色谱柱分离,0.1%甲酸水-甲醇作为流动相进行梯度洗脱,电喷雾正离子(ESI+)模式电离,多反应监测(MRM)模式检测,外标法定量。氟啶虫酰胺、TFNG、TFNA和TFNA-AM的检出限分别为0.17、0.20、0.35和0.60 μg/kg。在黄瓜和苹果样品中添加5.0～2000 μg/kg水平的氟啶虫酰胺、TFNG、TFNA和TFNA-AM,其平均添加回收率在82.9%～104.1%范围内,批内分析相对标准偏差(RSD)在3.6%～6.9%之间。4种物质的峰面积与其浓度在0.50～200 μg/L范围内均呈良好的线性关系,线性回归系数均大于0.998。前处理步骤仅用有机溶剂6 mL。整个方法具有高灵敏度、准确、稳定的特点。     

Identification of unstable metabolites of Lonafarnib using liquid chromatography-quadrupole time-of-flight mass spectrometry, stable isotope incorporation and ion source temperature alteration

Structural characterization of unstable metabolites and other drug-derived entities poses a serious challenge to the analytical chemist using instrumentation such as LC-MS and LC-MS/MS, and may lead to inaccurate identification of metabolite structures. The task of structural elucidation becomes even more difficult when an analyte is unstable in the ion source of the mass spectrometer. However, a judicious selection of the experimental conditions and the advanced features of new generation mass spectrometers can often overcome these difficulties. We describe here the identification of three drug-derived peaks (A, B and C) that were detected from a Schering-Plough developmental compound (Lonafarnib) following incubation with cDNA-expressed human CYP3A4. Definitive characterization was achieved using (1) accurate mass measurement, (2) stable isotope incorporation, (3) reduced ion source temperature, (4) alkali ion attachment and (5) MS/MS fragmentation studies. The protonated ions of compounds A and B fragmented almost completely in the source, yielding ions of the same mass-to-charge ratio (m/z) as that of protonated C (CH+). Fortunately, the presence of Na+ and K+ adducts of A and B provided information crucial to distinguishing AH+ and BH+ from their fragment ions. Metabolite A was shown to be an unstable hydroxylated metabolite of Lonafarnib. The metabolite C was shown to be a dehydrogenated metabolite of Lonafarnib (Lonafarnib-2H), unstable in the presence of protic solvents. Finally, B was artifactually formed most likely from C by the solvolytic addition of methanol during sample preparation. MS/MS fragmentation experiments assisted in identifying the site of metabolism in A and chemical modification in B. A and C readily interconvert through hydration/dehydration, and B and C through addition/elimination of methanol present in the sample-processing solvents. Finally, NMR experiments were performed to confirm the structures of A and C.     

液相色谱-串联质谱法测定肉及肉制品中利谷隆及其代谢产物3,4-二氯苯胺残留

建立了液相色谱-串联质谱分析多种肉及肉制品中利谷隆及其代谢产物3,4-二氯苯胺残留的方法。样品用丙酮-乙腈(5:95, v/v)提取,冷冻去脂,经弗罗里硅土固相萃取柱净化后进行液相色谱-串联质谱检测,采用内标法定量。利谷隆及3,4-二氯苯胺在1～500 μg/L范围内呈良好的线性关系,相关系数(r)均大于0.998,方法的定量限(信噪比(S/N)＞10)为10 μg/kg,检出限(S/N＞3)为5 μg/kg。在各种肉及肉制品基质中添加低、中、高3种不同水平的利谷隆及3,4-二氯苯胺,其回收率范围分别为88.3%～101.2%和91.6%～101.6%,相对标准偏差(RSD)分别为4.8%～13.7%和4.7%～11.8%。结果表明所建立的方法可以满足肉及肉制品中利谷隆和3,4-二氯苯胺残留量的检测需要。     

液相色谱-串联质谱法测定食用植物油中的棉酚

建立了食用植物油中棉酚的液相色谱-串联质谱（LC-MS/MS）分析方法。待测物经无水乙醇涡旋振荡提取,C18色谱柱分离,以乙腈和0.1%（v/v）甲酸水溶液为流动相进行梯度洗脱,LC-MS/MS测定,外标法定量。方法的测定低限（S/N>10）为1 mg/kg;在添加浓度为1、2和200 mg/kg水平下,棉酚的加标回收率为87.4%~100%,相对标准偏差为3.9%~12.2%。结果表明,本方法灵敏度高,测定结果准确,回收率稳定,可用于食用植物油中棉酚残留的确证检测。     

Nitrofuran antibiotic metabolites detected at parts per million concentrations in retina of pigs--a new matrix for enhanced monitoring of nitrofuran abuse

Nitrofuran metabolite residues AOZ, AMOZ, AHD and SEM were detected at parts per million concentrations in retina of pigs fed therapeutic doses of nitrofuran antibiotics. Discovery of this residue depot may allow widespread technology transfer to laboratories lacking LC-MS/MS thus improving global monitoring of these drugs.     

液相色谱-串联质谱法检测蜂蜜中杀虫脒及其代谢产物残留

建立了液相色谱-串联质谱分析洋槐蜜、荆条蜜、蜂巢蜜、杂花蜜、野蜂蜜中杀虫脒及其代谢产物残留的方法。样品经氢氧化钠水溶液稀释溶解后,采用Waters Oasis HLB固相萃取柱净化。样品提取液经Agilent XDB-C18色谱柱分离,以0.1%甲酸水溶液和乙腈为流动相进行梯度洗脱。以电喷雾正离子(ESI+)模式电离,多反应监测(MRM)模式检测,基质匹配标准溶液外标法定量。杀虫脒及其代谢产物(4-氯邻甲苯胺)在2.5～250 μg/L范围内呈线性相关,相关系数(r)均大于0.999;定量限(S/N＞10)为5 μg/kg,检出限(S/N＞3)为2.5 μg/kg。各种蜂蜜基质样品在5、10和20 μg/kg添加水平时,杀虫脒及其代谢产物的回收率范围分别为75.8%～113.8%和85.6%～114.3%,相对标准偏差(RSD)分别为4.8%～10.2%和4.7%～9.1%,可以满足蜂蜜中杀虫脒及其代谢产物残留量的检测需要。     

Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometry

Besides affecting the systemic bioavailability of the parent drug, drug metabolizing enzymes (DMEs) may produce bioactive and/or toxic metabolites of clinical interest. We have investigated the capability to analyze simultaneously the parent drug and newly identified metabolites in patients' plasma by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The anticancer drug, imatinib, was chosen as a model drug because it has opened a new area in cancer therapy and is given orally and chronically. In addition, resistance and rare but sometimes severe side effects have been reported with this therapy. The quantification of imatinib and the profiling of its metabolites in plasma were established following three steps: (1) set-up of a generic sample extraction and LC-MS/MS conditions, (2) metabolite identification by LC-MS/MS using either in vitro incubations performed with human liver microsomes (HLMs) or patient plasma samples, (3) the simultaneous determination of plasma levels of imatinib and 14 metabolites in the plasma samples of 38 patients. Partial or cross method validation has been done and revealed that precise determinations of metabolite levels can be performed whereas pure standards are not available. Preliminary results indicate that the disposition of imatinib and its metabolites is related to interindividual variables and that outlier metabolite profiles can be revealed. This article underscores that, in addition to usual therapeutic drug monitoring (TDM), LC-MS/MS methods can simultaneously record a complete drug metabolic profile enabling various correlation studies of clinical interest.